The number of people diagnosed with liver cancer in the UK is 10 times higher now than it was at the end of the 1970s.  It continues to be seen as a cancer caused by alcoholism and a high risk lifestyle.  Perhaps for this reason, research into these highly aggressive tumours has lagged behind the advances made in breast and bowel cancer.  With the rise in diabetes and fatty liver, liver cancer is set to become one of the UK's biggest killers in the coming decades. Join us to hear about the efforts going on in Edinburgh to try and tackle this pariah cancer.  We are using lessons learned from how stem cells behave and regenerate the damaged liver to better understand how these tumours grow and how we can develop new drugs to tackle this often untreatable and fatal disease.

Speakers Rachel Guest, Division of Health Sciences; and Luke Boulter, MRC Human Genetics Unit